CBUS Cibus, Inc. logo

CBUS Cibus, Inc.

Healthcare
$1.38+0.00%ClosedMarket Cap: $62.8M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

PEG

P/B

25.36

P/S

14.65

EV/EBITDA

-4.95

DCF Value

$-0.65

FCF Yield

-80.7%

Div Yield

0.0%

Margins & Returns

Gross Margin

72.1%

Operating Margin

-1375.7%

Net Margin

-2366.3%

ROE

-225.6%

ROA

-31.3%

ROIC

-18.8%

Financials

View All
PeriodRevenueNet IncomeEPS
Q1 null$1.7M$-21.2M$
Q4 null$1.1M$-31.3M$
FY null$3.6M$-127.1M$
Q3 null$615.0K$-23.5M$

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$11.50

Target (Median)

$11.50

Target Range

$10.50 - $12.50

0 Strong Buy2 Buy1 Hold0 Sell0 Strong Sell
JefferiesHold
2026-03-25
Canaccord GenuityBuy
2025-12-08

Trading Activity

Insider Trades

View All
Urban Thomasdirector
SellTue Apr 28
Stokes Jasonofficer: CAO, Gen Csl & Corp Secy
SellTue Apr 28
Stokes Jasonofficer: CAO, Gen Csl & Corp Secy
SellTue Apr 28
Sauer Noelofficer: Sr VP, Research
SellTue Apr 28
Sauer Noelofficer: Sr VP, Research
SellTue Apr 28

Company Info

Sector

Healthcare

Industry

Biotechnology

Country

US

Exchange

Beta

1.66

Cibus, Inc., a agricultural technology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases. The company is based in San Diego, California.

Peers